Tuesday, November 16, 2021
Print Current Session:
|
|
Tuesday
SESSION 8:
MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NATURAL HISTORY; NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TBADs
|
|
SESSION 8 SCHEDULE | |
4:56 PM - 5:01 PM | Long-Term Outcomes Of Medically Managed Acute TBADs: How Were Patients Selected For This Treatment |
Presenter(s):Thomas C. Bower, MD Location: Grand Ballroom East, 3rd Floor |
|
MEGA DEBATE ON TREATMENT OF ACUTE UNCOMPLICATED TBADs | |
5:02 PM - 5:07 PM | DEBATE: Many Uncomplicated Acute TBADs Never Need Invasive Interventions And Are Better Treated Medically; How To Select Such Patients |
Presenter(s):Rachel E. Clough, MD, PhD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
5:08 PM - 5:13 PM | DEBATE: With Uncomplicated Acute TBADs, The Case For Waiting 2-6 Weeks From Onset And Then Limiting Aortic Coverage With TEVAR |
Presenter(s):Mark A. Farber, MD Location: Grand Ballroom East, 3rd Floor |
|
5:14 PM - 5:19 PM | DEBATE: With Uncomplicated TBADs, The Case For Early TEVAR With Extensive Aortic Coverage In Most Patients |
Presenter(s):William D. Jordan Jr., MD Location: Grand Ballroom East, 3rd Floor |
|
5:20 PM - 5:25 PM | DEBATE: Early Intervention For Acute TBADs (7-30 Days After Onset) With TEVAR For Acute TBADs Prevents Abdominal Extension Of False Lumen And TAAA Formation |
Presenter(s):Rodney A. White, MD Location: Grand Ballroom East, 3rd Floor |
|
5:26 PM - 5:31 PM | Ideal Timing And Patient Selection Of TEVAR In Acute Uncomplicated TBAD Patients: When Is Medical Treatment Indicated |
Presenter(s):Ali Azizzadeh, MD Location: Grand Ballroom East, 3rd Floor |
|
5:32 PM - 5:36 PM | [SS] Varying Solutions To Treat Type 1A Endoleaks After TEVAR And EVAR |
Presenter(s):Nicola Mangialardi, MD Location: Grand Ballroom East, 3rd Floor |
|
5:36 PM - 5:40 PM | [SS] Impact Of Cocaine Abuse On The Course Of Acute TBADs And Their Treatment: What Is The Mechanism |
Presenter(s):Frank R. Arko, MD Location: Grand Ballroom East, 3rd Floor |
|
5:40 PM - 5:45 PM | Techniques For And Advantages Of Rerouting A Misplaced TEVAR Which Is Leading To A Growing False Lumen And Malperfusion In Acute TBAD Patients |
Presenter(s):David M. Williams, MD Location: Grand Ballroom East, 3rd Floor |
|
5:46 PM - 5:51 PM | Re-Entry Specific Endovascular Therapy (RESET), i.e. TEVAR Plus Dealing With Re-Entry Tears Improves Outcomes: How To Do It |
Presenter(s):Jean M. Panneton, MD Location: Grand Ballroom East, 3rd Floor |
|
5:52 PM - 5:58 PM | Panel Discussion End Of Program A |
END OF SESSION 8 | |
previous | next |